Botanix Pharmaceuticals Limited (BXPHF) Stock Statistics & Valuation Metrics

Botanix Pharmaceuticals Limited has a market cap or net worth of $41.26M. The enterprise value is $34.48.

Botanix Pharmaceuticals Limited has 2,736,612,800 shares outstanding. The number of shares has decreased by -2.65% in one year.

Botanix Pharmaceuticals Limited’s return on equity (ROE) is -1.10 and return on invested capital (ROIC) is -77.62%.

The current PE Ratio of Botanix Pharmaceuticals Limited is ―. Botanix Pharmaceuticals Limited’s PEG ratio is 0.02.

In the last 12 months, Botanix Pharmaceuticals Limited had revenue of 34.51M and earned -69.77M in profits. Earnings per share was -0.03.

In the last 12 months, operating cash flow was -64.60M and capital expenditures 4.00, giving a free cash flow of -64.60M billion.

Botanix Pharmaceuticals Limited pays an annual dividend of ―, resulting in a dividend yield of ―

Botanix Pharmaceuticals Limited upcoming earnings date is Mar 3, 2027, TBA (Confirmed).

Botanix Pharmaceuticals Limited as a current ratio of 2.59, with Debt / Equity ratio of 23.21%

In the past 12 months, Botanix Pharmaceuticals Limited has paid 0.00 in taxes.

Botanix Pharmaceuticals Limited EV to EBITDA ratio is -0.28, with an EV/FCF ratio of -0.30.

Botanix Pharmaceuticals Limited has $36.63M in cash and marketable securities with $14.74M in debt, giving a net cash position of $21.89M billion.

Gross margin is -172.20%, with operating margin of -200.82%, and net profit margin of -202.15%.

The average price target for Botanix Pharmaceuticals Limited is $0.41, which is 11.43% higher than the current price. The consensus rating is Moderate Buy